CSat Investment Advisory’s Elevance Health ELV Stock Holding History

CSat Investment Advisory’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$10K	Buy	27 +3	+13%	+$965	0.01%	449
2020 Q4	$8K	Sell	24 -810	-97%	-$249K	0.01%	448
2020 Q3	$224K	Buy	834 +75	+10%	+$20.2K	0.02%	253
2020 Q2	$200K	Buy	759 +178	+31%	+$47.5K	0.02%	311
2020 Q1	$132K	Buy	581 +85	+17%	+$23.2K	0.03%	300
2019 Q4	$150K	Buy	496 +64	+15%	+$17.6K	0.04%	274
2019 Q3	$104K	Buy	432 +54	+14%	+$14.8K	0.03%	308
2019 Q2	$107K	Buy	378 +365	+2,808%	+$99.7K	0.04%	287
2019 Q1	$4K	Hold	13	–	–	﹤0.01%	516
2018 Q4	$3K	Buy	13 +2	+18%	+$550	﹤0.01%	516
2018 Q3	$3K	Buy	11 +1	+10%	+$260	﹤0.01%	508
2018 Q2	$2K	Buy	+10	New	+$2.32K	﹤0.01%	526
2014 Q4	–	Sell	-109,182	Closed	-$13.1M	–	23
2014 Q3	$13.1M	Buy	109,182 +11,470	+12%	+$1.32M	5.46%	4
2014 Q2	$10.5M	Buy	97,712 +22,216	+29%	+$2.29M	5.24%	5
2014 Q1	$7.52M	Sell	75,496 -32,738	-30%	-$2.96M	3.85%	6
2013 Q4	$10M	Buy	+108,234	New	+$9.62M	3.95%	9

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CSat Investment Advisory's ELV Position: Q1 2021 in Review

CSat Investment Advisory increased its Elevance Health (ELV) stake by 13% in Q1 2021, buying an estimated $965 and bringing the position to 27 shares worth $10K. The position accounts for 0.01% of the portfolio, ranked #449.

CSat Investment Advisory first reported a position in ELV in Q4 2013 and has held it in 16 quarters since. The position peaked at $13.1M in Q3 2014. 1,212 funds tracked by Wall St. Rank hold ELV as of Q1 2021.

CSat Investment Advisory held 27 shares of Elevance Health worth $10K as of Q1 2021.
CSat Investment Advisory bought 3 Elevance Health shares in Q1 2021, an estimated $965.
Elevance Health made up 0.01% of CSat Investment Advisory's portfolio in Q1 2021, its #449 holding.
CSat Investment Advisory first reported a position in Elevance Health in Q4 2013 and has held it in 16 quarters since.
CSat Investment Advisory's Elevance Health position peaked at $13.1M in Q3 2014.
1,212 funds tracked by Wall St. Rank held Elevance Health as of Q1 2021.

Based on CSat Investment Advisory's 13F filing for Q1 2021, filed 13 May 2021.